Literature DB >> 11819707

Multiple genetic alterations and behavior of cellular biology in gastric cancer and other gastric mucosal lesions:H.pylori infection, histological types and staging.

Heng-Jun Gao, Lian-Zhen Yu, Jian-Feng Bai, Yan-Shen Peng, Gu Sun, Han-Lin Zhao, Kun Miu, Xiu-Zhen L , Xiao-Yong Zhang, Zhi-Quan Zhao.   

Abstract

AIM:To investigate the expression of multiple genes and the behavior of cellular biology in gastric cancer (GC) and other gastric mucosal lesions and their relations to Helicobacter pylori (H. pylori) infection, tumor staging and histological subtypes.
METHODS: Three hundred and twenty seven specimens of gastric mucosa obtained via endoscopy or surgical resection, and ABC immunohistochemical staining were used to detect the expression of p53, p16, Bcl-2 and COX-2 proteins.H. pylori was determined by rapid urea test combined with patholo-gical staining or 14 Curea breath test. Cellular image analysis was performed in 66 patients with intestinal metaplasia (IM) and/or dysplasia (Dys). In 30 of them, both cancer and the paracancerous tissues were obtained at the time of surgery. Histolo-gical pattern, tumor staging, lymph node metastasis, grading of differentiation and other clinical data were studied in the medical records.
RESULTS: p16 expression of IM or Dys was significantly lower in positive H. pylori chronic atrophic gastritis (CAG) than those with negative H. pylori (CAG: 54.8% vs 88.0%, IM:34.4% vs 69.6%, Dys: 23.8% vs 53.6%, all P < 0.05), Bcl-2 or COX-2 expression of IM or Dys in positive H. pylori cases was signi-ficantly higher than that without H. pylori (Bcl-2: 68.8% vs 23.9%, 90.5% vs 60.7%; COX-2: 50.0% vs 10.8%, 61.8% vs 17.8%; all P <0.05). The mean number of most parame-ters of cellular image analysis in positive H. pylori group was significantly higher than that in negative H. pylori group (Ellipser: 53 plus minus 14, 40 plus minus 12&mgr;m, Area(1): 748 plus minus 572, 302 plus minus 202&mgr;m(2), Area(2): 3050 plus minus 1661, 1681 plus minus 1990&mgr;m(2), all P< 0.05; Ellipseb: 79 plus minus 23, 58 plus minus 15&mgr;m, Ratio-1: 22% plus minus5%,13% plus minus4%,Ratio-2:79% plus minus17%,53% plus minus20%,all P<0.01). There was significant correl-ation between Bcl-2 and histologic pattern of gastric carcinoma, and between COX-2 and tumor staging or lymph node metasta sis (Bcl-2: 75.0% vs16.7%; COX-2: 76.0% vs 20.0%, 79.2% vs 16.7%; all P< 0.05).
CONCLUSION: p16, Bcl-2, and COX-2 but not p53 gene may play a role in the early genesis/progression of gastric carcinoma and are associated with H. pylori infection. p53 gene is relatively late event in gastric tumorigenesis and mainly relates to its progression. There is more cellular-biological behavior of malignant tumor in gastric mucosal lesions with H. pylori infec-tion. Aberrant Bcl-2 protein expression appears to be preferentially associated with the intestinal type cancer. COX-2 seems to be related to tumor staging and lymph node metastasis.

Entities:  

Year:  2000        PMID: 11819707      PMCID: PMC4728273          DOI: 10.3748/wjg.v6.i6.848

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  48 in total

1.  Cooccurrence of reduced expression of alpha-catenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer.

Authors:  C Xiangming; S Hokita; S Natsugoe; G Tanabe; M Baba; S Takao; K Kuroshima; T Aikou
Journal:  Oncology       Date:  1999       Impact factor: 2.935

2.  Frequent detection of aberrant RNA transcripts of the CDKN2 gene in human gastric adenocarcinoma.

Authors:  Y J Chen; J G Chang; L S Shih; P H Chen; M Endo; J Whang-Peng; Y M Chen
Journal:  Int J Cancer       Date:  1997-05-02       Impact factor: 7.396

3.  Expression of bcl-2 protein in gastric carcinoma and its significance.

Authors:  Hai-Feng Liu; Wei-Wen Liu; Dian-Chun Fang; Rong-Pu Men
Journal:  World J Gastroenterol       Date:  1998-06       Impact factor: 5.742

4.  Prognostic value of bcl-2 expression in gastric cancer.

Authors:  W Müller; A Schneiders; G Hommel; H E Gabbert
Journal:  Anticancer Res       Date:  1998 Nov-Dec       Impact factor: 2.480

5.  [The pattern of p53 oncoprotein expression in gastric cancer patients].

Authors:  I Pálka; L Tiszlavicz
Journal:  Orv Hetil       Date:  1999-05-23       Impact factor: 0.540

6.  Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.

Authors:  C T Shun; M S Wu; J T Lin; S Y Chen; H P Wang; W J Lee; T H Wang; S M Chuang
Journal:  Hepatogastroenterology       Date:  1997 Mar-Apr

7.  Effect of Helicobacter pylori infection on gastric epithelial proliferation in progression from normal mucosa to gastriccarcinoma.

Authors:  Wen-Zhong Liu; Xiong Zheng; Yao Shi; Quan-Jiang Dong; Shu-Dong Xiao
Journal:  World J Gastroenterol       Date:  1998-06       Impact factor: 5.742

8.  Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

Authors:  S J Kuerbitz; B S Plunkett; W V Walsh; M B Kastan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

9.  Molecular mechanism of stomach carcinogenesis.

Authors:  E Tahara
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

10.  Prognostic value of p53 protein expression for patients with gastric cancer--a multivariate analysis.

Authors:  Y Maehara; M Tomoda; S Hasuda; A Kabashima; E Tokunaga; Y Kakeji; K Sugimachi
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

View more
  31 in total

Review 1.  Current gene therapy for stomach carcinoma.

Authors:  C T Xu; L T Huang; B R Pan
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

2.  Identification of antigens by monoclonal antibody PD4 and its expression in Escherichia coli.

Authors:  Jin-Ying Ning; Guo-Xun Sun; Su Huang; Hong Ma; Ping An; Lin Meng; Shu-Mei Song; Jian Wu; Cheng-Chao Shou
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

3.  FT-IR spectroscopic analysis of normal and cancerous tissues of esophagus.

Authors:  Jian-Sheng Wang; Jing-Sen Shi; Yi-Zhuang Xu; Xiao-Yi Duan; Li Zhang; Jing Wang; Li-Ming Yang; Shi-Fu Weng; Jin-Guang Wu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

4.  Expression, deletion [was deleton] and mutation of p16 gene in human gastric cancer.

Authors:  X S He; Q Su; Z C Chen; X T He; Z F Long; H Ling; L R Zhang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

5.  Anti-Helicobacter pylori immunoglobulin G (IgG) and IgA antibody responses and the value of clinical presentations in diagnosis of H. pylori infection in patients with precancerous lesions.

Authors:  Shao Li; Ai-Ping Lu; Lian Zhang; Yan-Da Li
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

6.  Association of cyclooxygenase-2 expression with Hp-cagA infection in gastric cancer.

Authors:  Xiao-Lin Guo; Li-Er Wang; Shu-Yan Du; Chen-Ling Fan; Li Li; Peng Wang; Yuan Yuan
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

7.  Construction of expression systems for flaA and flaB genes of Helicobacter pylori and determination of immunoreactivity and antigenicity of recombinant proteins.

Authors:  Jie Yan; Shao-Hui Liang; Ya-Fei Mao; Li-Wei Li; Shu-Ping Li
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

8.  Construction of hpaA gene from a clinical isolate of Helicobacter pylori and identification of fusion protein.

Authors:  Ya-Fei Mao; Jie Yan; Li-Wei Li; Shu-Ping Li
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

9.  Expression of NGF family and their receptors in gastric carcinoma: a cDNA microarray study.

Authors:  Jian-Jun Du; Ke-Feng Dou; Shu-You Peng; Bing-Zhi Qian; Hua-Sheng Xiao; Feng Liu; Wei-Zhong Wang; Wen-Xian Guan; Zhi-Qing Gao; Ying-Bin Liu; Ze-Guang Han
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

10.  Construction of prokaryotic expression system of ureB gene from a clinical Helicobacter pylori strain and identification of the recombinant protein immunity.

Authors:  Ya-Fei Mao; Jie Yan
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.